• Commissioner August 16, 2018 2:35 pm

    FDA Approves Teva's Generic EpiPen After Yearslong Delay

    U.S. regulators cleared the first generic competitor to Mylan’s EpiPen, after a yearslong delay that many said contributed to the emergency allergy drug’s rapid rise in price. Teva Pharmaceuticals received Food and Drug Administration approval for generic versions of both the EpiPen and EpiPen Jr, the agency said in a statement Tuesday.

  • New Hampshire August 19, 2017 3:04 pm

    New Hampshire to Get $1M in EpiPen Settlement

    New Hampshire will be getting $1 million from EpiPen maker Mylan as part of a national settlement.

  • Congress January 12, 2017 11:42 am

    CVS Puts Out Cheaper Generic Competitor to EpiPen

    CVS is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to consumers. The drugstore chain says it will charge $109.99 for a two-pack of the authorized generic version of Adrenaclick, a lesser-known treatment...

  • CEO December 16, 2016 10:05 am

    Mylan to Offer Generic EpiPen for $300 Next Week

    Mylan is about to start selling a generic version of its EpiPen injector for $300 per two-pack, under half the cost of the name-brand lifesaving drug, the pharmaceutical company announced Friday. The move comes after 20 state attorneys general launched a federal lawsuit alleging that Mylan and five other generic drug-makers artificially inflated and manipulated prices to reduce competition for...

Contact Us